ConductScience.org, home

Paper19633031

Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.

Nakagawa T and 8 others. Evid Based Complement Alternat Med, 2011. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model. Papers, record 19633031. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19633031

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.
PubMed
Journal
Evid Based Complement Alternat Med
PubMed
Year
2011
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2021-10-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakagawa TTakako
2Tashiro IIzumi
3Fujimoto MMakoto
4Jo MMichiko
5Sakai SShinya
6Oka HHiroshi
7Goto HHirozo
8Shimada YYutaka
9Shibahara NNaotoshi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19437375Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?Arch Intern Med1998https://conductscience.org/library/papers/9437375PubMed
28158904Macrophages in renal injury.Kidney Int Suppl1994https://conductscience.org/library/papers/8158904PubMed
315905195Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.Nephrol Dial Transplant2005https://conductscience.org/library/papers/15905195PubMed
4940276Pathogenesis of the glomerulopathy associated with renal infarction in rats.Kidney Int1976https://conductscience.org/library/papers/940276PubMed
54173786Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis.Lancet1968https://conductscience.org/library/papers/4173786PubMed
611012882Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.Kidney Int2000https://conductscience.org/library/papers/11012882PubMed
73345677Natural course of the development of histological lesions after 5/6 nephrectomy.Contrib Nephrol1988https://conductscience.org/library/papers/3345677PubMed
81313122Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model.Kidney Int1992https://conductscience.org/library/papers/1313122PubMed
99140991Pathogenesis of diabetic nephropathy: a radical approach.Nephrol Dial Transplant1997https://conductscience.org/library/papers/9140991PubMed
1015070171Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats.Phytomedicine2004https://conductscience.org/library/papers/15070171PubMed
119407465Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II.Kidney Int Suppl1997https://conductscience.org/library/papers/9407465PubMed
128178943Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).Am J Pathol1994https://conductscience.org/library/papers/8178943PubMed
138007597Macrophages in acute glomerular inflammation.Kidney Int1994https://conductscience.org/library/papers/8007597PubMed
149294829Osteopontin in chronic puromycin aminonucleoside nephrosis.J Am Soc Nephrol1997https://conductscience.org/library/papers/9294829PubMed
159075120Focal glomerulosclerosis in the remnant kidney model--an inflammatory disease mediated by cytokines.Nephrol Dial Transplant1997https://conductscience.org/library/papers/9075120PubMed
1617123761Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats.J Ethnopharmacol2007https://conductscience.org/library/papers/17123761PubMed
179530275Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis.Am J Physiol1998https://conductscience.org/library/papers/9530275PubMed
1816109081Role of impaired peritubular capillary and hypoxia in progressive interstitial fibrosis after 56 subtotal nephrectomy of rats.Nephrology (Carlton)2005https://conductscience.org/library/papers/16109081PubMed
198004960Transforming growth factor-beta and extracellular matrix deposition in the kidney.Contrib Nephrol1994https://conductscience.org/library/papers/8004960PubMed
207643523Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria.Kidney Int1995https://conductscience.org/library/papers/7643523PubMed

See all 35 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
37680217Efficacy of keishibukuryogan for hot flashes in prostate cancer patients receiving androgen deprivation therapy: a sub-analysis focusing on hormonal and cytokine levels.Transl Androl Urol2023https://conductscience.org/library/papers/37680217PubMed
35529925The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35529925PubMed
35004802A Review on the Mechanism and Application of Keishibukuryogan.Front Nutr2021https://conductscience.org/library/papers/35004802PubMed
30741979Phosphate binding by sucroferric oxyhydroxide ameliorates renal injury in the remnant kidney model.Sci Rep2019https://conductscience.org/library/papers/30741979PubMed
30235697Traditional Chinese medicine decreases the obstructive uropathy risk in uterovaginal prolapse: A nationwide population-based study.Medicine (Baltimore)2018https://conductscience.org/library/papers/30235697PubMed
24864155Protective Effects of Bu-Shen-Huo-Xue Formula against 5/6 Nephrectomy-Induced Chronic Renal Failure in Rats.Evid Based Complement Alternat Med2014https://conductscience.org/library/papers/24864155PubMed
20177750Study of blood porphyrin spectral profile for diagnosis of chronic renal failure.J Fluoresc2010https://conductscience.org/library/papers/20177750PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19633031

GET https://conductscience.org/api/papers/v1/19633031/references?page=2